From Diagnosis to Targeted Therapy: Analyzing the 14.8% CAGR of the Precision Genomic Testing Market Fueled by Oncology and Neurological Advances
Description: This post details the high-growth trajectory of the Precision Genomic Testing Market, outlining its critical role in oncology, neurological disorders, and rare diseases, and exploring how technological advancements like Next-Generation Sequencing (NGS) and the use of AI are driving its projected CAGR of 14.8% through 2030.
Blog Post 1/1
The Precision Genomic Testing Market is at the heart of the shift toward personalized medicine, providing the crucial data needed for accurate diagnosis and highly targeted treatment strategies. The market is witnessing exponential growth, estimated to reach over $\$35$ billion by 2030, driven by an impressive Compound Annual Growth Rate (CAGR) of 14.8%. This expansion is fueled by the rising prevalence of genetic disorders and chronic diseases, where genomic information is essential for effective management.
Technological sophistication is the core driver, with…